C4xd12 Apr 2018 08:55
Pretty impressed they got the 10 million in the bank so quickly. First payment of many market will wake up to the potential here soon. C4XD's proprietary drug asset portfolio of ten programmes across a number of therapeutic areas, including inflammation, neurodegeneration, immuno-oncology, addiction and diabetes, has progressed towards revenue generation.